Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer



Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy

Volume:19   Issue: 5
Pp: 349-359
Guillaume Poiroux, Annick Barre, Pierre Rougé and Hervé Benoist*
DOI: 10.2174/1568009618666180628101059




Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer

Volume:19   Issue: 5
Pp: 360-367
Junsong Chen, Na Niu, Jing Zhang, Lisha Qi, Weiwei Shen, Krishna Vanaja Donkena, Zhenqing Feng and Jinsong Liu*
DOI: 10.2174/1568009618666180703154233




Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions

Volume:19   Issue: 5
Pp: 368-381
Linh N.K. Tran*, Ganessan Kichenadasse and Pamela J. Sykes
DOI: 10.2174/1568009618666180724111604




The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy

Volume:19   Issue: 5
Pp: 382-399
Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*
DOI: 10.2174/1568009618666181031145953




Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity

Volume:19   Issue: 5
Pp: 400-407
Jie An* and M. Saeed Sheikh*
DOI: 10.2174/1568009618666171129222159




In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors

Volume:19   Issue: 5
Pp: 408-416
Nousheen Bibi*, Zahida Parveen, Muhammad Sulaman Nawaz and Mohammad Amjad Kamal
DOI: 10.2174/1568009619666181127115015